UBS Maintains Neutral on Healthpeak Properties, Lowers Price Target to $20
UBS maintains Healthpeak Properties (NYSE:DOC) with a Neutral and lowers the price target from $21.5 to $20.
Stocks · News reference
Barclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21
Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and lowers the price target from $24 to $21.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Evercore ISI Group Maintains In-Line on Healthpeak Properties, Lowers Price Target to $22
Evercore ISI Group analyst James Kammert maintains Healthpeak Properties (NYSE:DOC) with a In-Line and lowers the price target from $23 to $22.
Jefferies Assumes Healthpeak Properties at Hold, Lowers Price Target of $21
Jefferies analyst Joe Dickstein assumes Healthpeak Properties (NYSE:DOC) with a Hold rating and lowers Price Target of $21.